JOHNSON JOHN sold 16.2% of their position (135.40K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $977.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/19/2025ACC: 0001410781-25-000006
Director
Since Oct 2021
-135.40K
Net shares
Net seller
$977.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
135.40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−135.40K
Price / share
$7.22
Trade value
$977.02K
% of position
16.2%
12/19/2025
833.48K→698.08K
Total
Net shares
−135.40K
Net value
-$977.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | S · Sale | −135.40K | $7.22 | $977.02K | 16.2% | 833.48K | 698.08K |
| Total | −135.40K | -$977.02K | ||||||
Derivative Transactions0
No derivative transactions reported